We have made impressive progress in maternal, newborn and child survival in the last decade and a half. However, the burden continues to become more complex, and to meet the targets laid out in the Sustainable Development Goals, we will need to double the rate of progress made during the Millennium Development Goal era. We believe that the fastest way to interrupt the transfer of risk from mother to baby is to address underlying biological vulnerabilities, such as malnutrition and pre-term birth.
Our Growth and Resilience framework shifts focus away from development of tools for single disease conditions, and towards innovative tools that can alter the trajectory of biological vulnerability – potential game-changers for maternal, newborn and child survival. To develop these tools, our focus is on innovating in areas that reduce adverse birth outcomes, improve growth, optimize neurodevelopment, and enhance resilience to infection.